Ausgabe 1/2021
Inhalt (30 Artikel)
Is bioimpedance spectroscopy a useful tool for objectively assessing lymphovenous bypass surgical outcomes in breast cancer-related lymphedema?
Amanda Sutherland, Jamie L. Wagner, Sabrina Korentager, James Butterworth, Amanda L. Amin, Christa R. Balanoff, Amanda Hangge, Kelsey E. Larson
Effect of time to breast cancer surgery after neoadjuvant chemotherapy on survival outcomes
Mahmoud Al-Masri, Basim Aljalabneh, Hani Al-Najjar, Tamador Al-Shamaileh
Breast cancer in Colombia: a growing challenge for the healthcare system
Carlos Duarte, Alejandro Salazar, Kathrin Strasser-Weippl, Esther de Vries, Carolina Wiesner, Angélica Arango-Gutiérrez, Lindsay Krush, Paul E. Goss
Fourth-generation chimeric antigen receptor T cells targeting folate receptor alpha antigen expressed on breast cancer cells for adoptive T cell therapy
Piriya Luangwattananun, Mutita Junking, Jatuporn Sujjitjoon, Yupanun Wutti-in, Naravat Poungvarin, Chanitra Thuwajit, Pa-thai Yenchitsomanus
HDAC6 inhibition enhances the anti-tumor effect of eribulin through tubulin acetylation in triple-negative breast cancer cells
Takaaki Oba, Mayu Ono, Hisanori Matoba, Takeshi Uehara, Yoshie Hasegawa, Ken-ichi Ito
Metabolic Syndrome: does this influence breast cancer outcomes in the triple-negative population?
Kaitlyn Kennard, Meghan E. Buckley, Lina M. Sizer, Sharon Larson, William B. Carter, Thomas G. Frazier, Ned Z. Carp
ZNF703 gene copy number and protein expression in breast cancer; associations with proliferation, prognosis and luminal subtypes
Elise Klæstad, Joanna Ewa Sawicka, Monica Jernberg Engstrøm, Borgny Ytterhus, Marit Valla, Anna Mary Bofin
N-myristoyltransferase proteins in breast cancer: prognostic relevance and validation as a new drug target
John R. Mackey, Justine Lai, Utkarsh Chauhan, Erwan Beauchamp, Wei-Feng Dong, Darryl Glubrecht, Yie-Wei Sim, Sunita Ghosh, Gilbert Bigras, Raymond Lai, Luc G. Berthiaume
Cancer stem cell transcriptome landscape reveals biomarkers driving breast carcinoma heterogeneity
Zhifa Zhang, Xiao Chen, Jianying Zhang, Xiaofeng Dai
HER2 fluorescent in situ hybridization signal degradation: a 10-year retrospective study
Jessie M. Wu, Andrey-Ann Galibois, Neha Seebocus, Anupam Apu, Marta Hnatovska, Annie Wilson, Teresa Shortill, Gulisa Turashvili
A phase I safety study of topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopecia
Mario E. Lacouture, Hedy Dion, Shobha Ravipaty, Joaquin J. Jimenez, Khampaseuth Thapa, Eric M. Grund, Ely Benaim, Nikunj Tanna, Shen Luan, Nathaniel DiTommaso, Niven R. Narain, Rangaprasad Sarangarajan, Elder Granger, Brian Berman, Shari B. Goldfarb
Clinical validity of clinical treatment score 5 (CTS5) for estimating risk of late recurrence in unselected, non-trial patients with early oestrogen receptor-positive breast cancer
Juliet Richman, Alistair Ring, Mitch Dowsett, Ivana Sestak
Clinical significance of HER2 status in T1bN0 breast cancer: a nationwide study from the Korean Breast Cancer Society
Young-Joon Kang, Se Jeong Oh, Hoon Choi, Shijin Cho, Chang-Hyun Shin, Chaiwon Kim, Joohyun Woo, JungSun Lee, Heung Kyu Park, Han-Byoel Lee, Woo Chul Noh, Yong-Seok Kim
Relationships between pathological factors and long-term outcomes in patients enrolled in two prospective randomized controlled trials comparing the efficacy of oral tegafur–uracil with CMF (N·SAS-BC 01 trial and CUBC trial)
Shinji Ohno, Shigehira Saji, Norikazu Masuda, Hitoshi Tsuda, Futoshi Akiyama, Masafumi Kurosumi, Akihiko Shimomura, Nobuaki Sato, Shintaro Takao, Shozo Ohsumi, Yutaka Tokuda, Hideo Inaji, Toru Watanabe, Yasuo Ohashi
Association between VEGF single nucleotide polymorphism and breast cancer in the Northern China Han population
Ziyao Li, Ying Wang, Cong Liu, Zhenzhen Wang, Dongmo Wang, Xingyu Liang, Jiawei Tian
Response to neoadjuvant chemotherapy and the 21-gene Breast Recurrence Score test in young women with estrogen receptor-positive early breast cancer
Tal Sella, Shari I. Gelber, Philip D. Poorvu, Hee-Jeong Kim, Laura Dominici, Yaileen D. Guzman-Arocho, Laura Collins, Kathryn J. Ruddy, Rulla M. Tamimi, Jeffrey M. Peppercorn, Lidia Schapira, Virginia F. Borges, Steven E. Come, Ellen Warner, Craig Snow, Debbie M. Jakubowski, Christy A. Russell, Eric P. Winer, Shoshana M. Rosenberg, Ann H. Partridge
Long-term effects of adjuvant treatment for breast cancer on carotid plaques and brain perfusion
Vincent Koppelmans, Kimberly D. van der Willik, Berthe M. P. Aleman, Flora E. van Leeuwen, Maryam Kavousi, Banafsheh Arshi, Meike W. Vernooij, M. Arfan Ikram, Sanne B. Schagen
The relationship between the predicted risk of death and psychosocial functioning among women with early-stage breast cancer
Kelly A. Metcalfe, Alexandra Candib, Vasily Giannakeas, Andrea Eisen, Aletta Poll, David McCready, Tulin Cil, Frances C. Wright, Susan Armel, Karen Ott, Ping Sun, Steven A. Narod
Association of relative dose intensity with BMI and pathologic complete response in patients treated with neoadjuvant chemotherapy for breast cancer
Ilana Usiskin, Fangyong Li, Melinda L. Irwin, Brenda Cartmel, Tara Sanft
Drug use disorder and risk of incident and fatal breast cancer: a nationwide epidemiological study
Disa Dahlman, Hedvig Magnusson, Xinjun Li, Jan Sundquist, Kristina Sundquist
Presentation and characteristics of breast cancer in young women under age 40
Xueying Hu, Kelly S. Myers, Eniola T. Oluyemi, Mary Philip, Armina Azizi, Emily B. Ambinder
Cyclin-dependent kinase 4/6 inhibitors and interstitial lung disease in the FDA adverse event reporting system: a pharmacovigilance assessment
Emanuel Raschi, Michele Fusaroli, Andrea Ardizzoni, Elisabetta Poluzzi, Fabrizio De Ponti
Potential of using mammography screening appointments to identify high-risk women: cross sectional survey results from the national health interview survey
Anand K. Narayan, Sarah F. Mercaldo, Yasha P. Gupta, Erica T. Warner, Constance D. Lehman, Randy C. Miles
Risk of chemotherapy-related amenorrhoea (CRA) in premenopausal women undergoing chemotherapy for early stage breast cancer
Arran K. Turnbull, Samir Patel, Carlos Martinez-Perez, Anne Rigg, Olga Oikonomidou
Spindle and kinetochore‑associated complex subunit 3 accelerates breast cancer cell proliferation and invasion through the regulation of Akt/Wnt/β-catenin signaling
Jian Zhang, Yang Liu, Shengyu Pu, Jianjun He, Can Zhou
Double heterozygosity for TP53 and BRCA1 mutations: clinical implications in populations with founder mutations
Hagit Shani, Rinat Bernstein-Molho, Yael Laitman, Iris Netzer, Eitan Friedman
Germline BRCA-mutated metastatic breast cancer with positive hormone receptor
Michela Palleschi, Maria Laura Iaia, Chiara Casadei
Letter to the Editor regarding the publication titled “Axillary lymph node dissection in node-positive breast cancer: are ten nodes adequate and when is enough, enough?”
Rosa Di Micco, Jean-Marc Classe, Toralf Reimer
Letter to the editor re: Shah et al.: “The impact of monitoring techniques on progression to chronic breast cancer‑related lymphedema: a meta‑analysis comparing bioimpedance spectroscopy versus circumferential measurements”
Bolette Skjødt Rafn, Jan Christensen, Kira Bloomquist
Letter to editor re: Shah et al.: “The impact of monitoring techniques on progression to chronic breast cancer-related lymphedema: a meta-analysis comparing bioimpedance spectroscopy versus circumferential measurements”
Cheryl L. Brunelle, Andrea V. Barrio, Alphonse G. Taghian